Polaris to launch algal DHA in softgel at FIE

[France] Polaris is launching its ultra-stable algal DHA Omega-3 in vegan softgel format at Food Ingredients Europe, enabling it to offer four EFSA claims in one capsule.

Each capsule delivers an optimal 250mg of DHA Omega-3 from microalgae in a 100% plant-based shell, making it the ideal solution for consumers seeking a vegan or vegetarian alternative to gelatin capsules.

DHA contributes to the maintenance of normal vision

DHA contributes to the maintenance of normal brain function

DHA maternal intake contributes to the normal development of the eye of the foetus and breastfed children

DHA maternal intake contributes to the normal brain development of the foetus and breastfed children.

Véronique Sancéau, Marketing Manager at Polaris, said: “Consumer demand for the many health benefits of Omega-3 remains extremely high and in a competitive market an EFSA claim has never been more important. By offering our algal oil an optimal dose, we’re providing four health claims in a single convenient capsule.”

The oil offers unmatched stability, thanks to Polaris’ unique Qualitysilver® industrial methodology. Testing has shown it to be around three times more stable than standard algal oil.

Polaris’ algal oil is 100% produced in Europe, non-GMO, allergen-free, and extracted naturally without solvents. In addition, it has just received kosher certification and Halal certification is expected by the end of the year. It has also received “Non-GMO Verification” accreditation for sales in the US.

Véronique Sancéau, Marketing Manager at Polaris, added: “We’re excited to be offering our customers DHA Omega-3 in a capsule format that enables them to target key health markets. Our algal oil is not only animal-free and produced naturally, it is now also certified kosher and non-GMO and will be soon halal certified, helping us meet worldwide market demand even more effectively.”

Polaris will be exhibiting at Food Ingredients Europe (28-30 November in Frankfurt) in the French Pavilion (Stand 11.OF93) where innovations on algae will be featured.

Furthermore, one capsule per day opens up the possibility of four different EFSA health claims: